Research use only · Not for human or veterinary use · Qualified buyers only
← Catalogue
Triple Agonist 30mg lyophilised peptide vial
Research use onlyNot for human consumption
Peptide · CAS —

Triple Agonist 30mg

Multi-target synthetic peptide targeting GLP-1, GIP, and glucagon receptor pathways for comparative in-vitro metabolic research. Supplied as lyophilised powder for laboratory research use only.

§ Research applications

Investigated in pre-clinical models of glucose homeostasis, insulin secretion and appetite-related metabolic signalling through combined GLP-1, GIP and glucagon receptor activation (Coskun et al., Mol. Metab., 2018).

Citations provided for pre-clinical reference only. Supplied strictly for in-vitro research — not a claim of clinical efficacy.

OrderIn stock · ships 48h
Price
£80.00
per 30 mg vial · ex. VAT & shipping

Items are held in your Zenitide basket. Review and proceed to secure checkout when ready.

Request CoA only
  • Dispatched in 24–48h
    Once payment has cleared
  • Insulated packaging
    Protects lyophilised compounds in transit
  • Tracked UK delivery
    Tracking reference emailed on dispatch
Per-batch CoA included with every shipment
Sale restricted to qualified researchers & institutional laboratories. For in-vitro research use only — not for human or veterinary use.
§ Specification
CAS Number
—
Molecular Formula
Single synthetic 39-amino-acid peptide
Molecular Weight
—
Purity
≥ 98.0% (HPLC)
Category
Peptide
Formulation
Lyophilised powder
Presentation
Refrigerated (2–8 °C); −20 °C for long-term storage
Vial Size
30 mg
SKU
ZEN-TA-30
Triple Agonist 30mg
£80.00